Derivation of New Human Embryonic Stem Cell Lines: Identification of Instructive Factors for Germ Cells Development

NCT ID: NCT01165918

Last Updated: 2010-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is

1. To generate human embryonic stem cells lines (hESC) lines
2. Study of the factors that contribute to differentiation towards germ cell.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Normal Healthy Embryos

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Donated embryos

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* any donated embryos

Exclusion Criteria

* not relevant
Minimum Eligible Age

2 Days

Maximum Eligible Age

4 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ben-Gurion University of the Negev

OTHER

Sponsor Role collaborator

Soroka University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Soroka Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Soroka medical center

Beersheba, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eitan Lunenfeld, MD and Prof.

Role: CONTACT

- 972-8-6460058

Rivka Ofir

Role: CONTACT

97286477272

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rivka Ofir, PhD

Role: primary

972 8 6477272

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sor491210CTIL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Discarded Materials Study
NCT01219335 RECRUITING
Effects of Embryogen in RIF Patients
NCT02250768 COMPLETED PHASE4